Pure Global

Prognostic Model Heart Failure - Trial NCT06414928

Access comprehensive clinical trial information for NCT06414928 through Pure Global AI's free database. This phase not specified trial is sponsored by National Institute of Cardiovascular Diseases, Pakistan and is currently Recruiting. The study focuses on Heart Failure Acute. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06414928
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT06414928
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Prognostic Model Heart Failure
In-hospital & 30-day Prognostication of Acute Heart Failure Patients by Comparing 4 Validated Scores in Patients Presenting to the Emergency Department of Cardiac Tertiary Care Hospital, Karachi- Pakistan

Study Focus

Heart Failure Acute

Acute Heart Failure

Observational

other

Sponsor & Location

National Institute of Cardiovascular Diseases, Pakistan

Karachi, Pakistan

Timeline & Enrollment

N/A

Feb 14, 2024

Jun 14, 2026

1000 participants

Primary Outcome

In-Hospital Prognosis,30-day Prognosis

Summary

This study aims to determine the prognosis of heart failure in our population by using
 multiple validated risk scores and to evaluate the strengths of these scores in assessing
 prognosis with better discrimination.

ICD-10 Classifications

Heart failure
Heart failure, unspecified
Congestive heart failure
Injury of heart
Injury of heart, unspecified

Data Source

ClinicalTrials.gov

NCT06414928

Non-Device Trial